+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Umbilical Cord Blood Banking Market Research Report by Storage (Private Cord Blood Banks and Public Cord Blood Banks), Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 4896802
  • Report
  • April 2022
  • Region: Global
  • 186 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • Americord Registry LLC
  • Caladrius Biosciences
  • Cord Blood America, Inc.
  • Cordlife Group
  • Cordvida
  • Esperite N.V.
The Global Umbilical Cord Blood Banking Market size was estimated at USD 20.85 billion in 2021, USD 24.29 billion in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 16.70% to reach USD 52.67 billion by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Umbilical Cord Blood Banking to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Storage, the market was studied across Private Cord Blood Banks and Public Cord Blood Banks.
  • Based on Application, the market was studied across Bone Marrow Failure Syndrome, Immune Deficiencies, Leukemia, Lymphoma, and Metabolic Disorder.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.

This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Umbilical Cord Blood Banking market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Umbilical Cord Blood Banking Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Umbilical Cord Blood Banking Market, including Amag Pharmaceuticals, Inc., Americord Registry LLC, Caladrius Biosciences, China Cord Blood Corporation, Cord Blood America, Inc., Cord Blood Registry Systems, Inc., Cordlife Group, Cordvida, Cryo-Cell International, Inc., Esperite N.V., Lifeforce Cryobank Sciences, Inc, National Cord Blood Program, Perkinelmer, Inc., Smart Cells International Ltd., StemCyte Inc, ViaCord LLC, Virgin Group Limited, and Vita 34 AG.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Umbilical Cord Blood Banking Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Umbilical Cord Blood Banking Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Umbilical Cord Blood Banking Market?
4. What is the competitive strategic window for opportunities in the Global Umbilical Cord Blood Banking Market?
5. What are the technology trends and regulatory frameworks in the Global Umbilical Cord Blood Banking Market?
6. What is the market share of the leading vendors in the Global Umbilical Cord Blood Banking Market?
7. What modes and strategic moves are considered suitable for entering the Global Umbilical Cord Blood Banking Market?
Frequently Asked Questions about the Global Umbilical Cord Blood Banking Market

What is the estimated value of the Global Umbilical Cord Blood Banking Market?

The Global Umbilical Cord Blood Banking Market was estimated to be valued at $20.9 Billion in 2021.

What is the growth rate of the Global Umbilical Cord Blood Banking Market?

The growth rate of the Global Umbilical Cord Blood Banking Market is 16.7%, with an estimated value of $52.7 Billion by 2027.

What is the forecasted size of the Global Umbilical Cord Blood Banking Market?

The Global Umbilical Cord Blood Banking Market is estimated to be worth $52.7 Billion by 2027.

Who are the key companies in the Global Umbilical Cord Blood Banking Market?

Key companies in the Global Umbilical Cord Blood Banking Market include Amag Pharmaceuticals, Inc., Americord Registry LLC, Caladrius Biosciences, China Cord Blood Corporation, Cord Blood America, Inc., Cord Blood Registry Systems, Inc., Cordlife Group, Cordvida and Cell International, Inc..
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Americord Registry LLC
  • Caladrius Biosciences
  • Cord Blood America, Inc.
  • Cordlife Group
  • Cordvida
  • Esperite N.V.

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing due to the increasing prevalence of chronic diseases coupled with the regenerative medicines
5.1.1.2. Rising applications of cord blood and stem cells in genetic disease treatment
5.1.2. Restraints
5.1.2.1. High cost of storage, collection, and risk of non-usability of the unit stored with a private bank
5.1.3. Opportunities
5.1.3.1. Rising government initiatives and funding in developed economies
5.1.3.2. Potential new developments and launches in the cord blood banking
5.1.4. Challenges
5.1.4.1. Strict license and accreditation procedures of UCB banking
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. Umbilical Cord Blood Banking Market, by Storage
6.1. Introduction
6.2. Private Cord Blood Banks
6.3. Public Cord Blood Banks
7. Umbilical Cord Blood Banking Market, by Application
7.1. Introduction
7.2. Bone Marrow Failure Syndrome
7.3. Immune Deficiencies
7.4. Leukemia
7.5. Lymphoma
7.6. Metabolic Disorder
8. Americas Umbilical Cord Blood Banking Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Umbilical Cord Blood Banking Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
10. Europe, Middle East & Africa Umbilical Cord Blood Banking Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. Amag Pharmaceuticals, Inc.
12.2. Americord Registry LLC
12.3. Caladrius Biosciences
12.4. China Cord Blood Corporation
12.5. Cord Blood America, Inc.
12.6. Cord Blood Registry Systems, Inc.
12.7. Cordlife Group
12.8. Cordvida
12.9. Cryo-Cell International, Inc.
12.10. Esperite N.V.
12.11. Lifeforce Cryobank Sciences, Inc
12.12. National Cord Blood Program
12.13. Perkinelmer, Inc.
12.14. Smart Cells International Ltd.
12.15. StemCyte Inc
12.16. ViaCord LLC
12.17. Virgin Group Limited
12.18. Vita 34 AG
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET: DYNAMICS
FIGURE 2. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, 2021 VS 2027 (%)
FIGURE 3. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, 2021 VS 2027 (USD BILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, 2027
FIGURE 5. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PRIVATE CORD BLOOD BANKS, 2019-2027 (USD BILLION)
FIGURE 6. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PRIVATE CORD BLOOD BANKS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 7. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PUBLIC CORD BLOOD BANKS, 2019-2027 (USD BILLION)
FIGURE 8. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PUBLIC CORD BLOOD BANKS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 9. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 10. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD BILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2027
FIGURE 12. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BONE MARROW FAILURE SYNDROME, 2019-2027 (USD BILLION)
FIGURE 13. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BONE MARROW FAILURE SYNDROME, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 14. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY IMMUNE DEFICIENCIES, 2019-2027 (USD BILLION)
FIGURE 15. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY IMMUNE DEFICIENCIES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 16. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY LEUKEMIA, 2019-2027 (USD BILLION)
FIGURE 17. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY LEUKEMIA, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 18. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY LYMPHOMA, 2019-2027 (USD BILLION)
FIGURE 19. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY LYMPHOMA, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 20. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY METABOLIC DISORDER, 2019-2027 (USD BILLION)
FIGURE 21. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY METABOLIC DISORDER, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 22. AMERICAS UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 23. ARGENTINA UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 24. BRAZIL UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 25. CANADA UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 26. MEXICO UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 27. UNITED STATES UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 28. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 29. AUSTRALIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 30. CHINA UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 31. INDIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 32. INDONESIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 33. JAPAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 34. MALAYSIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 35. PHILIPPINES UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 36. SINGAPORE UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 37. SOUTH KOREA UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 38. TAIWAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 39. THAILAND UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 40. EUROPE, MIDDLE EAST & AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 41. FRANCE UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 42. GERMANY UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 43. ITALY UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 44. NETHERLANDS UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 45. QATAR UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 46. RUSSIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 47. SAUDI ARABIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 48. SOUTH AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 49. SPAIN UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 50. UNITED ARAB EMIRATES UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 51. UNITED KINGDOM UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 52. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET: FPNV POSITIONING MATRIX
FIGURE 53. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 54. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL UMBILICAL CORD BLOOD BANKING MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY STORAGE, 2019-2027 (USD BILLION)
TABLE 4. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PRIVATE CORD BLOOD BANKS, BY REGION, 2019-2027 (USD BILLION)
TABLE 5. AMERICAS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PRIVATE CORD BLOOD BANKS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 6. UNITED STATES UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PRIVATE CORD BLOOD BANKS, BY STATE, 2019-2027 (USD BILLION)
TABLE 7. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PRIVATE CORD BLOOD BANKS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PRIVATE CORD BLOOD BANKS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 9. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PUBLIC CORD BLOOD BANKS, BY REGION, 2019-2027 (USD BILLION)
TABLE 10. AMERICAS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PUBLIC CORD BLOOD BANKS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 11. UNITED STATES UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PUBLIC CORD BLOOD BANKS, BY STATE, 2019-2027 (USD BILLION)
TABLE 12. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PUBLIC CORD BLOOD BANKS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY PUBLIC CORD BLOOD BANKS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 14. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY APPLICATION, 2019-2027 (USD BILLION)
TABLE 15. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BONE MARROW FAILURE SYNDROME, BY REGION, 2019-2027 (USD BILLION)
TABLE 16. AMERICAS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BONE MARROW FAILURE SYNDROME, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 17. UNITED STATES UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BONE MARROW FAILURE SYNDROME, BY STATE, 2019-2027 (USD BILLION)
TABLE 18. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BONE MARROW FAILURE SYNDROME, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 19. EUROPE, MIDDLE EAST & AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY BONE MARROW FAILURE SYNDROME, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 20. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY IMMUNE DEFICIENCIES, BY REGION, 2019-2027 (USD BILLION)
TABLE 21. AMERICAS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY IMMUNE DEFICIENCIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 22. UNITED STATES UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY IMMUNE DEFICIENCIES, BY STATE, 2019-2027 (USD BILLION)
TABLE 23. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY IMMUNE DEFICIENCIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 24. EUROPE, MIDDLE EAST & AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY IMMUNE DEFICIENCIES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 25. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY LEUKEMIA, BY REGION, 2019-2027 (USD BILLION)
TABLE 26. AMERICAS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY LEUKEMIA, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 27. UNITED STATES UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY LEUKEMIA, BY STATE, 2019-2027 (USD BILLION)
TABLE 28. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY LEUKEMIA, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 29. EUROPE, MIDDLE EAST & AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY LEUKEMIA, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 30. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY LYMPHOMA, BY REGION, 2019-2027 (USD BILLION)
TABLE 31. AMERICAS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY LYMPHOMA, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 32. UNITED STATES UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY LYMPHOMA, BY STATE, 2019-2027 (USD BILLION)
TABLE 33. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY LYMPHOMA, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 34. EUROPE, MIDDLE EAST & AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY LYMPHOMA, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 35. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY METABOLIC DISORDER, BY REGION, 2019-2027 (USD BILLION)
TABLE 36. AMERICAS UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY METABOLIC DISORDER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 37. UNITED STATES UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY METABOLIC DISORDER, BY STATE, 2019-2027 (USD BILLION)
TABLE 38. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY METABOLIC DISORDER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 39. EUROPE, MIDDLE EAST & AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, BY METABOLIC DISORDER, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 40. AMERICAS UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 41. ARGENTINA UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 42. BRAZIL UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 43. CANADA UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 44. MEXICO UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 45. UNITED STATES UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 46. ASIA-PACIFIC UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 47. AUSTRALIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 48. CHINA UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 49. INDIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 50. INDONESIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 51. JAPAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 52. MALAYSIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 53. PHILIPPINES UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 54. SINGAPORE UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 55. SOUTH KOREA UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 56. TAIWAN UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 57. THAILAND UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 58. EUROPE, MIDDLE EAST & AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 59. FRANCE UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 60. GERMANY UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 61. ITALY UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 62. NETHERLANDS UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 63. QATAR UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 64. RUSSIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 65. SAUDI ARABIA UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 66. SOUTH AFRICA UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 67. SPAIN UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 68. UNITED ARAB EMIRATES UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 69. UNITED KINGDOM UMBILICAL CORD BLOOD BANKING MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 70. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET: SCORES
TABLE 71. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET: BUSINESS STRATEGY
TABLE 72. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET: PRODUCT SATISFACTION
TABLE 73. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET: RANKING
TABLE 74. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 75. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET: MERGER & ACQUISITION
TABLE 76. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 77. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 78. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET: INVESTMENT & FUNDING
TABLE 79. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 80. GLOBAL UMBILICAL CORD BLOOD BANKING MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Amag Pharmaceuticals, Inc.
  • Americord Registry LLC
  • Caladrius Biosciences
  • China Cord Blood Corporation
  • Cord Blood America, Inc.
  • Cord Blood Registry Systems, Inc.
  • Cordlife Group
  • Cordvida
  • Cryo-Cell International, Inc.
  • Esperite N.V.
  • Lifeforce Cryobank Sciences, Inc
  • National Cord Blood Program
  • Perkinelmer, Inc.
  • Smart Cells International Ltd.
  • StemCyte Inc
  • ViaCord LLC
  • Virgin Group Limited
  • Vita 34 AG
Note: Product cover images may vary from those shown

Loading
LOADING...